Citing the lack of childproof packaging, the U.S. Consumer Product Safety Commission recalled 407,050 units of four medications June 16. 

Marlborough, Mass.-based Boston Scientific entered into a definitive agreement to shell out $230 million for Synergy's M.I. Tech, a medical device manufacturer and distributor, for a 64 percent stake by the end of 2022.

Forty-nine states have requested vaccines for children under 5 from the federal government. Florida is the only state that didn't sign up, according to the Miami Herald. 

Less than two weeks after Abbott resumed producing infant formula at its Michigan plant, it's down again. This time, the problem is severe storm-induced flooding in parts of the factory, according to a June 15 press release. 

The U.S. is running dry on more than 100 treatments, including cardiovascular, antibiotic and anti-infective drugs, according to the FDA. 

Unlike recent national shortages of baby formula and contrast dye, there isn't data tracking the absence of tampons — but consumers are still struggling to find them. 

As the nation awaits the recovery of the infant formula supply — which the FDA predicts will come at the end of July — a Rhode Island hospital initiated a human pasteurized milk program in May, according to CBS News. 

Online healthcare supplier and 1-year-old company Bttn clinched a $20 million series A funding round with the help of existing investor Fuse. 

After the COVID-19 pandemic hindered personal protective equipment supply, Inova developed an isolation gown that can be washed and reused up to 100 times and slashes 213 tons of annual waste.

As CDC-reported cases of monkeypox rack up to 49 across 16 states and Washington, D.C., the U.S. ordered 500,000 more monkeypox vaccines from Bavarian Nordic. 

A recent Q&A with Mike Alvarez, head of Digital Services at Fuse, discusses health systems’ increasing need for data analytics and decision support.

Here are 10 health systems that have posted job listings for supply chain expertise in the last week: 

Medical supply company Cardinal Health anticipates its 208,144-square-foot distribution center in Grove City, Ohio, will be fully operational by November. 

Here are eight drug and device recalls that have been reported to the FDA since May 1:

While CT scans have been postponed for weeks or months after a COVID-19-related shutdown interrupted one plant's contrast dye production, hospitals could decrease their use up to 83 percent, according to research published June 9 in JAMA. 

Tampon manufacturers and suppliers are running to meet a higher demand, which could be the next supply shortage the healthcare industry faces, according to Time. 

A former Abbott employee submitted an Occupational Safety and Health Administration complaint in February 2021, months before the baby formula-producing plant in Sturgis, Mich., stopped operations, The Wall Street Journal reported June 8.

The contrast dye shortage, caused by COVID-19 lockdowns in China, has spurred leaders at healthcare systems across the nation to come up with innovative solutions to continue services with rationed supplies.

Minneapolis-based Medtronic recalled 1,614 pump implants developed for the company's HeartWare ventricular assist device, which the FDA deemed a class 1 recall, the highest level, June 8. 

After failing to pass another COVID-19 relief package, the federal government is veering off course and investing $10 billion for vaccines and the antiviral treatment Paxlovid originally marked for tests and personal protective equipment, The New York Times reported.